SEEGENE, INC. Logo

SEEGENE, INC.

Develops multiplex PCR-based IVD products and automated diagnostic systems.

096530 | KO

Overview

Corporate Details

ISIN(s):
KR7096530001
LEI:
Country:
South Korea
Address:
서울특별시 송파구 오금로 91(방이동) 7층, 서울특별시

Description

Seegene, Inc. is a company specializing in molecular diagnostics. It develops and manufactures in vitro diagnostic (IVD) products and automated systems based on its proprietary multiplex real-time PCR technologies. These technologies enable the simultaneous detection of multiple pathogens from a single sample, facilitating a syndromic testing approach for various conditions. The company's portfolio includes a broad range of diagnostic assays for infectious diseases, including respiratory illnesses, sexually transmitted infections (STIs), and human papillomavirus (HPV). Seegene also provides automated platforms, such as its All-in-One systems, to streamline laboratory workflows. The company engages in technology-sharing initiatives and strategic collaborations to advance the standardization and accessibility of molecular diagnostics globally.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-03-06 00:00
주주총회집중일개최사유신고
Korean 4.9 KB
2024-03-06 00:00
현금ㆍ현물배당결정
Korean 9.6 KB
2024-03-06 00:00
중간(분기)배당을위한주주명부폐쇄(기준일)결정
Korean 5.3 KB
2024-03-06 00:00
주주총회소집공고
Korean 321.3 KB
2024-03-06 00:00
의결권대리행사권유참고서류
Korean 346.9 KB
2024-02-16 00:00
매출액또는손익구조30%(대규모법인은15%)이상변동
Korean 10.9 KB
2024-02-16 00:00
연결재무제표기준영업(잠정)실적(공정공시)
Korean 16.0 KB
2024-02-08 00:00
결산실적공시예고
Korean 4.2 KB
2024-01-17 00:00
자기주식처분결과보고서
Korean 15.4 KB
2024-01-15 00:00
주요사항보고서(자기주식처분결정)
Korean 25.5 KB
2023-12-15 00:00
주주명부폐쇄기간또는기준일설정
Korean 4.1 KB
2023-11-14 00:00
분기보고서 (2023.09)
Korean 1.1 MB
2023-11-10 00:00
연결재무제표기준영업(잠정)실적(공정공시)
Korean 16.7 KB
2023-11-08 00:00
현금ㆍ현물배당결정(분기배당)
Korean 8.4 KB
2023-11-03 00:00
결산실적공시예고
Korean 4.2 KB

Automate Your Workflow. Get a real-time feed of all SEEGENE, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for SEEGENE, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for SEEGENE, INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.